Armed With An FDA-Cleared IND, TLS Sets Out To Democratize Clinical Trials
Executive Summary
Transparency Life Sciences applies crowdsourcing to the design of clinical protocols with the aim of lowering costs and improving outcomes for clinical trials. The company won FDA clearance for its first IND based on a protocol that resulted from its process and is securing its first financing.